Sensorion SA Cash Flow Conversion Efficiency

Latest as of December 2025: -0.190x

Sensorion SA cash flow conversion efficiency. Based on the latest financial reports, Sensorion SA (ALSEN) has a cash flow conversion efficiency ratio of -0.190x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-8.45 Million ≈ $-9.88 Million USD) by net assets (€44.48 Million ≈ $52.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Sensorion SA (2012–2025)

Cash flow conversion efficiency of Sensorion SA from 2012 to 2025. This chart illustrates how Sensorion SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Sensorion SA stock price for real-time trading data and today's change.

Sensorion SA Cash Flow Conversion Ratio Explained

Sensorion SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Sensorion SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sensorion SA ranked by their cash flow conversion efficiency. Also see market value of Sensorion SA for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Dong Phu Rubber JSC VN:DPR	0.036x
GPT Healthcare Ltd NSE:GPTHEALTH	0.073x
Financiera Independencia S.A.B. de C.V. SOFOM E.N.R MX:FINDEP	0.035x
S.Kijchai Enterprise Public Company Limited BK:SKN	0.017x
Loxley Public Company Limited BK:LOXLEY	-0.044x
Associated Alcohols & Breweries Ltd. NSE:ASALCBR	0.080x
Meridian Holdings Inc NASDAQ:MRDN	0.152x
Adriano Care SOCIMI SAU MC:YADR	0.009x

Annual Cash Flow Conversion Efficiency for Sensorion SA (2012–2025)

The table below shows the annual cash flow conversion efficiency of Sensorion SA from 2012 to 2025. Review ALSEN free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€44.48 Million ≈ $52.00 Million	€-27.39 Million ≈ $-32.02 Million	-0.616x	-108.25%
2024-12-31	€72.14 Million ≈ $84.34 Million	€-21.33 Million ≈ $-24.94 Million	-0.296x	+53.30%
2023-12-31	€33.28 Million ≈ $38.90 Million	€-21.07 Million ≈ $-24.63 Million	-0.633x	+35.30%
2022-12-31	€21.87 Million ≈ $25.57 Million	€-21.41 Million ≈ $-25.02 Million	-0.979x	-299.56%
2021-12-31	€43.98 Million ≈ $51.42 Million	€-10.77 Million ≈ $-12.59 Million	-0.245x	-168.93%
2020-12-31	€58.35 Million ≈ $68.21 Million	€-5.31 Million ≈ $-6.21 Million	-0.091x	+91.51%
2019-12-31	€13.21 Million ≈ $15.45 Million	€-14.17 Million ≈ $-16.56 Million	-1.072x	+69.27%
2018-12-31	€3.51 Million ≈ $4.10 Million	€-12.25 Million ≈ $-14.32 Million	-3.489x	-228.29%
2017-12-31	€7.32 Million ≈ $8.56 Million	€-7.78 Million ≈ $-9.10 Million	-1.063x	-26.94%
2016-12-31	€8.59 Million ≈ $10.04 Million	€-7.19 Million ≈ $-8.41 Million	-0.837x	-112.45%
2015-12-31	€12.82 Million ≈ $14.99 Million	€-5.05 Million ≈ $-5.91 Million	-0.394x	-105.53%
2014-12-31	€-323.20K ≈ $-377.85K	€-2.30 Million ≈ $-2.69 Million	7.130x	+504.41%
2013-12-31	€-1.20 Million ≈ $-1.40 Million	€-1.42 Million ≈ $-1.66 Million	1.180x	+103.73%
2012-12-31	€26.11K ≈ $30.53K	€-826.03K ≈ $-965.71K	-31.636x	--

About Sensorion SA

PA:ALSEN France Biotechnology

Market Cap

$5.57 Billion

€4.77 Billion EUR

Market Cap Rank

#18242 Global

#266 in France

Share Price

€9.25

Change (1 day)

+0.98%

52-Week Range

€0.22 - €10.47

All Time High

€12.53